Tim Hui Ming Huang

Summary

Affiliation: University of Texas Health Science Center
Country: USA

Publications

  1. pmc Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers
    Rui Lan Huang
    Department of Obstetrics and Gynecology Tri Service General Hospital National Defense Medical Center Taiwan, Republic of China Laboratory of Epigenetics Cancer Stem Cells National Defense Medical Center Taiwan, Republic of China Institute of Biomedical Informatics of National Yang Ming University at Taipei Taiwan, Republic of China
    Epigenetics 8:624-34. 2013
  2. pmc Epigenetic deregulation of the anaplastic lymphoma kinase gene modulates mesenchymal characteristics of oral squamous cell carcinomas
    Tze Ta Huang
    Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, TX 78229, USA
    Carcinogenesis 34:1717-27. 2013
  3. pmc Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development
    Martín A Rivas
    Laboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental IBYME, CONICET, Vuelta de Obligado 2490, C1428ADN Buenos Aires, Argentina
    Breast Cancer Res 14:R77. 2012
  4. pmc Genome-wide analysis uncovers high frequency, strong differential chromosomal interactions and their associated epigenetic patterns in E2-mediated gene regulation
    Junbai Wang
    Department of Pathology, Oslo University Hospital Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
    BMC Genomics 14:70. 2013
  5. pmc Integrative genome-wide chromatin signature analysis using finite mixture models
    Cenny Taslim
    Department of Statistics, The Ohio State University, Columbus, Ohio 43210, USA
    BMC Genomics 13:S3. 2012
  6. doi request reprint Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer
    Chun Liang Chen
    Department of Molecular Medicine, Cancer Therapy and Research Center, University of Texas Health Science Center, San Antonio, Texas 78229 3900, USA
    Prostate 73:813-26. 2013

Collaborators

  • Devalingam Mahalingam
  • Maria E Gaczynska
  • Hung Cheng Lai
  • Jianhua Ruan
  • Ching Chih Lee
  • Tien Cheng Chang
  • Chun Liang Chen
  • Rui Lan Huang
  • Ian M Thompson
  • Junbai Wang
  • Kun Huang
  • Martín A Rivas
  • Cenny Taslim
  • Pawel Osmulski
  • Rohit R Jadhav
  • Victor X Jin
  • Fei Gu
  • Mu Hsien Yu
  • Luzhe Sun
  • Xun Lan
  • Hang Kai Hsu
  • Pei Yin Hsu
  • Jay M Pilrose
  • Cheng Chang Chang
  • Yu ping Liao
  • Nameer B Kirma
  • Chiou Miin Wang
  • Hui Chen Wang
  • Kenneth P Nephew
  • Jeffrey Parvin
  • Robin J Leach
  • Hsuan Cheng Huang
  • Addanki Pratap Kumar
  • Steven D Weitman
  • Shili Lin
  • Patricia V Elizalde
  • Yi Wen Huang
  • Leandro Venturutti
  • Roxana Schillaci

Detail Information

Publications6

  1. pmc Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers
    Rui Lan Huang
    Department of Obstetrics and Gynecology Tri Service General Hospital National Defense Medical Center Taiwan, Republic of China Laboratory of Epigenetics Cancer Stem Cells National Defense Medical Center Taiwan, Republic of China Institute of Biomedical Informatics of National Yang Ming University at Taipei Taiwan, Republic of China
    Epigenetics 8:624-34. 2013
    ..Methylation of ZIC1, a putative tumor suppressor, may be a novel determinant of OC outcome...
  2. pmc Epigenetic deregulation of the anaplastic lymphoma kinase gene modulates mesenchymal characteristics of oral squamous cell carcinomas
    Tze Ta Huang
    Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, TX 78229, USA
    Carcinogenesis 34:1717-27. 2013
    ..Given the complex response of OSCC cells to ALK inhibition, future studies are required to assess the feasibility of targeting ALK to treat invasive OSCCs. ..
  3. pmc Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development
    Martín A Rivas
    Laboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental IBYME, CONICET, Vuelta de Obligado 2490, C1428ADN Buenos Aires, Argentina
    Breast Cancer Res 14:R77. 2012
    ..The role of miRNA in progestin-induced breast cancer is poorly explored. In this study we explored progestin modulation of miRNA expression in mammary tumorigenesis...
  4. pmc Genome-wide analysis uncovers high frequency, strong differential chromosomal interactions and their associated epigenetic patterns in E2-mediated gene regulation
    Junbai Wang
    Department of Pathology, Oslo University Hospital Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
    BMC Genomics 14:70. 2013
    ..It provides informative results to address how chromatin organization changes contribute to disease/tumor occurrence and progression in response to stimulation of environmental chemicals or hormones...
  5. pmc Integrative genome-wide chromatin signature analysis using finite mixture models
    Cenny Taslim
    Department of Statistics, The Ohio State University, Columbus, Ohio 43210, USA
    BMC Genomics 13:S3. 2012
    ..Around 5% (431 regions) of these correlated regions do not overlap with any transcripts or regulatory regions suggesting that these might be potential new promoters or markers for other annotation which are currently undiscovered...
  6. doi request reprint Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer
    Chun Liang Chen
    Department of Molecular Medicine, Cancer Therapy and Research Center, University of Texas Health Science Center, San Antonio, Texas 78229 3900, USA
    Prostate 73:813-26. 2013
    ..Here we postulate that CTCs expressing genes related to epithelial-mesenchymal transition (EMT) are strong predictors of metastatic prostate cancer...